Goldman Sachs added Novo Nordisk (NYSE: NVO) to its Conviction Buy List, joining Roche (OTC: RHHBY) and Shire plc (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE